Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan, ROC.
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.
Eur J Pharmacol. 2017 Nov 5;814:248-254. doi: 10.1016/j.ejphar.2017.08.038. Epub 2017 Aug 30.
Vasoplegia impedes therapeutic interventions to restore vascular tone, leading to severe hypotension, poor tissue perfusion, and multiple organ failure in septic shock. High levels of circulating nitric oxide (NO) play a crucial role in endotoxin-induced vascular hyporeactivity. Proinflammatory cytokines have been implicated in the induction of inducible NO synthase and overproduction of NO. Anti-inflammatory therapy can diminish NO formation and improve vascular hyporeactivity in septic shock. STE20/SPS1-realted proline/alanine-rich kinase (SPAK) has been reported to activate mitogen-activated protein kinase and contribute to intestinal inflammation. Thus, we evaluated the roles of SPAK in NO production and vascular hyporeactivity in endotoxemic animals. Male wild-type and SPAK deficiency mice were intraperitoneally administered vehicle or Escherichia coli lipopolysaccharide (LPS, 50mg/kg). The changes of systolic blood pressure and plasma nitrate and nitrite levels were measured during the experimental period. Thoracic aortas were exercised to assess vascular reactivity and SPAK expression. In the present study, mice in endotoxin model showed severe hypotension and hyporeactivity to serotonin, phenylephrine (PE), and acetylcholine in the aortic rings. Phosphorylated SPAK expression in the aorta and NO levels in the plasma were also increased in animals with endotoxic shock. However, deletion of SPAK not only reduced the elevation of NO levels but also improved vascular hyporeactivity to serotonin and PE in endotoxemic mice. Taken together, SPAK could be involved in the NO overproduction and vascular hyporesponsiveness to vasoconstrictors in endotoxic shock. Thus, inhibition of SPAK could be useful in the prevention of endotoxin-induced vascular hyporeactivity.
血管麻痹会阻碍恢复血管张力的治疗干预,导致感染性休克时严重低血压、组织灌注不良和多器官衰竭。循环中高水平的一氧化氮 (NO) 在内毒素诱导的血管反应性低下中起着至关重要的作用。促炎细胞因子被认为参与诱导诱导型一氧化氮合酶和过量产生 NO。抗炎治疗可以减少 NO 的形成并改善感染性休克时的血管反应性低下。STE20/SPS1 相关脯氨酸/丙氨酸丰富激酶 (SPAK) 已被报道可激活丝裂原活化蛋白激酶并有助于肠道炎症。因此,我们评估了 SPAK 在内毒素血症动物中 NO 产生和血管反应性低下中的作用。雄性野生型和 SPAK 缺乏型小鼠经腹腔给予载体或大肠杆菌脂多糖 (LPS,50mg/kg)。在实验期间测量收缩压和血浆硝酸盐和亚硝酸盐水平的变化。对胸主动脉进行锻炼以评估血管反应性和 SPAK 表达。在本研究中,内毒素模型中的小鼠表现出严重的低血压和对血管环中 5-羟色胺、苯肾上腺素 (PE) 和乙酰胆碱的反应性低下。内毒素休克动物的主动脉中磷酸化 SPAK 表达和血浆中 NO 水平也升高。然而,SPAK 的缺失不仅降低了 NO 水平的升高,而且改善了内毒素血症小鼠对 5-羟色胺和 PE 的血管反应性低下。总之,SPAK 可能参与内毒素休克中 NO 产生过多和对血管收缩剂的血管反应性低下。因此,抑制 SPAK 可能有助于预防内毒素引起的血管反应性低下。